Although revascularizations in patients with peripheral artery disease (PAD) are meant to prevent amputations, a study published online Nov. 20 in JAMA Surgery found that areas in the country where revascularizations in the year before amputation were more frequent did not have lower rates of amputation. 

In a reversal from its 2009 opinion, the Centers for Medicare & Medicaid Services (CMS) is proposing to expand its coverage for cardiac rehabilitation services for patients with chronic heart failure.

Selectively ablating patients with atrial fibrillation reduces costs, according to a substudy of the DECAAF trial presented Nov. 18 at the American Heart Association scientific session in Dallas.

Americans are more likely to avoid seeking healthcare because of cost, access and insurance issues than residents of 10 other countries, according to a study published online Nov. 13 in Health Affairs.

More than one third of cardiovascular-related randomized controlled clinical trials funded by the National Heart, Lung, and Blood Institute (NHLBI) were published within 30 months of their completion, according to an analysis published Nov. 14 in the New England Journal of Medicine.

When it comes to value, warfarin may be the best option for reducing the risk of stroke and thromboembolism in patients with atrial fibrillation.

In response to rising national health care costs, the Indiana University School of Medicine and Indiana Clinical and Translational Sciences Institute have launched a new center to increase efficacy and reduce costs at four major health care providers across Indiana.

Demand for cardiology services will grow by 20 percent in the next dozen years, according to a recent projection. Maybe.